Web Stats Provided By Google Analytics

Wednesday, February 26, 2014

EMA Grants Orphan Drug Status To ImmunoCellular's ICT-107

The European Medicines Agency has granted orphan drug designation for ImmunoCellular Therapeutics' ICT-107 for the treatment of glioblastoma.

http://ift.tt/1co40OU

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts